Praxsyn Launches Credit Card Processing.


WEST PALM BEACH, Florida, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Praxsyn (OTC:PXYN) is pleased to provide this corporate update to all of our shareholders.

Praxsyn adds Credit Card processing to its portfolio of services.

After commencing origination and sales of its first pool of medical receivables to a private equity firm (the “Funder”) through its wholly-owned subsidiary, Praxsyn Capital Corporation, Praxsyn (the, “Company”), has begun to offer credit card processing services for the medical practices we are purchasing portfolios from, as well as providers that we don’t.

Our services will enable providers to finance procedures using a credit card, spreading the charges over up to 18 months, in addition to processing of co-pays and cash pay procedures.

Management anticipates as much as $36 Million in additional gross revenue, over the next 18 months and contributing as much as $1,000,000 or more in gross profits during that seem period.

Furthermore, the Company intends to offer medical billing services to practices that utilize any of our menu of services.

About Praxsyn Corporation

Headquartered in West Palm Beach, Florida, Praxsyn Corporation works to realize the vision of medical professionals to improve the lives of their patients. Additional company information can be found at www.praxsyncorp.com.

With a mid-market private equity firm that invests in growth companies, recapitalizes or backs new executives.

Forward-Looking Statements

This press release contains forward-looking statements that are subject to many risks and uncertainties. Forward-looking statements include, among other things, statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations. Such risks and uncertainties include, among others, the inherent uncertainties associated with developing new products or technologies, regulatory approvals, unexpected expenditures, the ability to raise the additional funding needed to continue to pursue Praxsyn's business and product development plans and overall market conditions. These forward-looking statements are made as of the date of this press release, and Praxsyn assumes no obligation to update the forward-looking statements.

We may use terms such as “projects,” “believes,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should,” “approximately,” or other words that convey the uncertainty of future events or outcomes to identify these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement contained herein, we caution you that forward-looking statements are not guarantees of future performance and that our actual results may differ materially from the forward-looking statements contained in this press release. As a result of these factors, we cannot assure you that the forward-looking statements in this press release will prove to be accurate.

Investor Contact:

Email: investors@praxsyncorp.com

Frank Brady, CEO

777 South Flagler Drive, Suite 800

West Palm Beach, Florida 33401-6161

f.brady@praxsyncapital.com
f.brady@praxsyncorp.com
o. 561.323.7338